Versions Compared


  • This line was added.
  • This line was removed.
  • Formatting was changed.


  1. Zhao B, Tan Y, Tsai WY, Qi J et al. Reproducibility of radiomics for deciphering tumor phenotype with imaging. Sci Rep. 2016 Mar 24;6:23428. (link)
  2. Li H, Zhu Y, Burnside ES, Huang E, et al. Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set. npj Breast Cancer (2016). (link)
  3. Grossmann P, Gutman DA, et al. Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma. BMC Cancer (2016). (link)
  4. Zhu Y, Li H, Guo W, Drukker K, et al. Deciphering Genomic Underpinnings of Quantitative MRI-based Radiomic Phenotypes of Invasive Breast Carcinoma. Sci Rep (2015). (link)
  5. Rajakumar K, Muttan S, Deepa G, Revathy S, Priya BS. Intelligent texture feature extraction and indexing for MRI image retrieval using curvelet and PCA with HTF. Advances in Natural and Applied Sciences. 2015 Jun 1;9(6 SE):506-13. (link)
  6. Parmar, C., R. T. Leijenaar, et al. (2015). "Radiomic feature clusters and Prognostic Signatures specific for Lung and Head &Neck cancer." Sci Rep 5: 11044.

  7.  Parmar, C., P. Grossmann, et al. (2015). "Machine Learning methods for Quantitative Radiomic Biomarkers." Sci Rep 5: 13087.
  8. Tanougast C, Chaddad A. High-Throughput Quantification of Phenotype Heterogeneity Using Statistical Features. Adv Bioinformatics (2015). (link)
  9. Chaddad A. Automated Feature Extraction in Brain Tumor by Magnetic Resonance Imaging Using Gaussian Mixture Models.  International Journal of Biomedical Imaging, 2015. (link)
  10. Dhara AK, Mukhopadhyay S, Khandelwal N. 3d texture analysis of solitary pulmonary nodules using co-occurrence matrix from volumetric lung CT images. SPIE 2013. (link)
  11. Dhara AK, Mukhopadhyay S, Alam N, Khandelwal N. Measurement of spiculation index in 3D for solitary pulmonary nodules in volumetric lung CT images. Proc. SPIE 8670, Medical Imaging 2013: Computer-Aided Diagnosis, 86700K. (link)


  1. Kalpathy-Cramer J, Freymann JB, Kirby JS, et al. Quantitative Imaging Network: Data Sharing and Competitive Algorithm Validation Leveraging The Cancer Imaging Archive Translational Oncology. 2014 Feb;7(1):147-52. doi: 10.1593/tlo.13862. (link)
  2. Huang W, Li X, Chen Y, Li X, Chang MC, Oborski MJ, Malyarenko DI, Muzi M, Jajamovich GH, Fedorov A, Tudorica A, Gupta SN, Laymon CM, Marro KI, Dyvorne HA, Miller JV, Barbodiak DP, Chenevert TL, Yankeelov TE, Mountz JM, Kinahan PE, Kikinis R, Taouli B, Fennessy F, Kalpahthy-Cramer J. Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challenge. Translational Oncology. 2014 Feb;7(1):153-66. (link)
  3. Clarke LP, Nordstrom RJ, Zhang H, Tandon P, et al. The Quantitative Imaging Network: NCI’s Historical Perspective and Planned Goals Translational Oncology. 2014 Feb;7(1):1-4. doi: (link)
  4. Levy MA, Freymann JB, Kirby JS, Fedorov A, Fennessy FM, Eschrich SA, Berglund AE, Fenstermacher DA, Tan Y, Guo X, Casavant TL, Brown BJ, Braun TA, Dekker A, Roelofs E, Mountz JM, Boada F, Laymon C, Oborski M, Rubin DL. Informatics methods to enable sharing of quantitative imaging research data. Magnetic Resonance Imaging. 2012 Nov;30(9):1249-56. doi: 10.1016/j.mri.2012.04.007. Epub 2012 Jul 6. (link)

Collection: QIN Breast

  1. Mohammed Ammar, Saïd Mahmoudi, Drisis Stylianos. Breast Cancer Response Prediction in Neoadjuvant Chemotherapy Treatment Based on Texture Analysis. Procedia Computer Science, Volume 100, 2016, Pages 812-817, ISSN 1877-0509, doi: 10.1016/j.procs.2016.09.229
  2. Li X, Abramson RG, Arlinghaus LR, Kang H, Chakravarthy AB, Abramson VG, Farley J, Mayer IA, Kelley MC, Meszoely IM, Means-Powell J, Grau AM, Sanders M, Yankeelov TE. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer. Investigative Radiology, 2015 Apr;50(4):195-204. PMCID: PMC4471951 doi: 10.1097/RLI.0000000000000100.
  3. Weis JA, Miga MI, Arlinghaus LR, Li X, Abramson V, Chakravarthy AB, Pendyala P, Yankeelov TE. Predicting the Response of Breast Cancer to Neoadjuvant Therapy Using a Mechanically Coupled Reaction-Diffusion Model. Cancer Res. 2015 Nov 15;75(22):4697-707. doi: 10.1158/0008-5472.CAN-14-2945.

  4. Atuegwu NC, Arlinghaus L, Li X, Welch EB, Chakravarthy AB, Gore JC, Yankeelov TE. Integration of diffusion weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemotherapy. Magnetic Resonance in Medicine 2011; 66:1689-96. PMCID: PMC3218213
  5. Li, X, Welch EB, Chakravarthy B, Mayer I, Meszeoly I, Kelley M, Means-Powell J, Gore JC, Yankeelov TE. Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer. Magnetic Resonance in Medicine, 2012; 68:261-71. PMCID: PMC3291742
  6. Smith DS, Gambrell JV, Li X, Arlinghaus LA, Quarles CC, Yankeelov TE, Welch EB. Robustness of Quantitative Compressive Sensing MRI: The Effect of Random Acquisitions on Derived Parameters for DCE and DSC-MRI. IEEE Transactions in Medical Imaging, 2012; 31:504-11. PMCID: PMC3289060
  7. Smith DS, Gore JC, Yankeelov TE, Welch EB. Real-time Compressive Sensing MRI Reconstruction using GPU Computing and Split Bregman Methods. International Journal of Biomedical Imaging, 2012; 2012:864827. PMCID: PMC3296267
  8. Dula AN, Arlinghaus LR, Dortch RD, Dewey BE, Whisenant JE, Ayers GD, Yankeelov TE, Smith SE. Amide Proton Transfer Imaging of the Breast at 3 T: Establishing reproducibility and possible feasibility for assessing chemotherapy response. Magnetic Resonance in Medicine, 2013; 70: 216-24. PMCID: PMC3505231
  9. Yankeelov TE, Peterson TE, Abramson RG, Garcia-Izquierdo D, Arlinghaus LR, Li X, Atuegwu NC, Catana C, Manning HC, Fayad ZA, Gore JC. Simultaneous PET-MRI in Oncology: A Solution Looking for a Problem? Magnetic Resonance Imaging, 2012; 30:1342-56. Selected as a Top 25 paper in Magnetic Resonance Imaging, 2012. PMCID: PMC3466373
  10. Abramson RG, Arlinghaus LR, Weis JA, Li X, Dula AN, Chekmenev EY, Smith SA, Miga MI, Abramson VG, Yankeelov TE. Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy. Breast Cancer: Targets and Therapies, 2012; 4: 139-154. PMCID: PMC3496377
  11. Li X, Abramson RG, Arlinghaus LR, Chakravarthy AB, Abramson V, Mayer I, Farley J, Delbeke D, Yankeelov TE. An Algorithm for Longitudinal Registration of PET/CT Images Acquired During Neoadjuvant Chemotherapy in Breast Cancer: Preliminary Results. European Journal of Nuclear Medicine and Molecular Imaging Research, 2012; 16:62. PMCID: PMC3520720
  12. Fluckiger U, Loveless ME, Barnes SL, Lepage M, Yankeelov TE. A diffusion-compensated model for the analysis of DCE-MRI data: theory, simulations, and experimental results. Physics in Medicine and Biology, 2013; 58:1983-98. PMCID: PMC3646091
  13. Yankeelov TE. Integrating Imaging Data into Predictive Biomathematical and Biophysical Models of Cancer. ISRN Biomathematics, 2012; Article ID 287394. PMCID: PMC3729405
  14. Atuegwu NC, Arlinghaus LR, Li X, Chakravarthy AB, Abramson VG, Sanders ME, Yankeelov TE. Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity During Neoadjuvant Chemotherapy. Translational Oncology, 2013; 6:253-64. PMCID: PMC3660793
  15. Klomp DWJ, Dula AN, Arlinghaus LR, Italiaander M, Dortch RD, Zu Z, Williams JM, Gochberg DF, Luijten PR, Gore JC, Yankeelov TE, Smith SA. Amide Proton Transfer Imaging of the Human Breast at 7 Tesla: Development and Reproducibility. NMR in Biomedicine, 2013; 26:1271-7. PMCID: PMC3726578
  16. Mani S, Chen Y, Li X, Arlinghaus L, Chakravarthy AB, Abramson V, Bhave SR, Levy MA, Xu H, Yankeelov TE. Machine Learning for Predicting the Response of Breast Cancer to Neoadjuvant Chemotherapy. Journal of the American Medical Informatics Association, 2013; 20:688-95. PMCID: PMC3721158
  17. Li X, Arlinghaus LR, Ayers GD, Chakravarthy AB, Abramson RG, Abramson VG, Atuegwu N, Farley J, Mayer IA, Kelley MC, Meszoely IM, Means-Powell J, Grau AM, Sanders M, Bhave SR, Yankeelov TE. DCE-MRI Analysis Methods for Predicting the Response of Breast Cancer to Neoadjuvant Chemotherapy: Pilot Study Findings. Magnetic Resonance in Medicine, 2014; 71(4):1592-602. PMCID: PMC3742614
  18. Yankeelov TE, Atuegwu N, Hormuth D, Weis JA, Barnes SL, Miga MI, Rericha EC, Quaranta V. Clinically relevant modeling of tumor growth and treatment response. Science Translational Medicine 2013; 5:187ps9. PMCID: PMC3938952
  19. Abramson RG, Hoyt TL, Wilson KJ, Li X, Arlinghaus LR, Su P-F, Abramson VG, Chakravarthy AB, Yankeelov TE. Early Assessment of Breast Cancer Response to Neoadjuvant Chemotherapy by Semi- Quantitative Analysis of High Temporal Resolution DCE-MRI: Preliminary Results. Magnetic Resonance Imaging, 2013 ; 31:1457-64. PMCID: PMC3807825
  20. Weis JA, Miga MI, Arlinghaus LA, Li X, Chakravarthy AB, Abramson VG, Farley J, Yankeelov TE. A mechanically coupled reaction-diffusion model for predicting the response of breast tumors to neoadjuvant chemotherapy. Physics of Medicine and Biology, 2013; 58:5851-66. PMCID: PMC3791925
  21. Smith DA, Yankeelov TE, Welch EB. Potential of Compressed Sensing in Quantitative MR Imaging of Cancer. Cancer Imaging, 2013; 13:633-44. PMCID: PMC3893904
  22. Fluckiger JU, Li X, Whisenant JG, Peterson TE, Gore JC, Yankeelov TE. Using dynamic contrast enhanced magnetic resonance imaging data to constrain a positron emission tomography kinetic model: theory and simulations. International Journal of Biomedical Imaging, 2013; 2013:576470. PMCID: PMC3814089
  23. Fedorov A, Fluckiger J, Ayers GD, Li X, Gupta SN, Mulkern R, Yankeelov TE, Fennessy FM. A Comparison of Two Methods for Estimating DCE-MRI Parameters via Individual and Cohort Based AIFs in Prostate Cancer: A Step Towards Practical Implementation. Magnetic Resonance Imaging, 2014; 32:321-9. PMCID: PMC3965600
  24. Li X, Kang H, Arlinghaus LR, Abramson RG, Chakravarthy AB, Abramson VG, Farley J, Sanders M, Yankeelov TE. Analyzing Spatial Heterogeneity in DCE- and DW-MRI Parametric Maps to Optimize Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer. Translational Oncology, 2014; 7:14-22. PMCID: PMC3998687
  25. Chenevert TL, Malyarenko DI, Newitt D, Hylton N, Huang W, Li X, Tudorica A, Fedorov A, Fennessy F, Kikinis R, Arlinghaus L, Li X, Yankeelov TE, Muzi M, Marro KI, Kinahan PE, Jajamovich GH, Dyvorne HA, Taouli B, Kalpathy-Cramer J, Oborski MJ, Laymon CM, Mountz JM, Ross BD. Error in Quantitative Image Analysis Due to Platform-Dependent Image Scaling. Translational Oncology, 2014; 7:65-71. PMCID: PMC3998685
  26. Huang W, Li X, Chen Y, Li X, Chang M-C, Oborski MJ, Malyarenko DI, Muzi M, Jajamovich GH, Federov A, Tudorica A, Gupta S, Laymon CM, Marro KI, Dyvorne HA, Miller JV, Chenevert TL, Yankeelov TE, Mountz JM, Kinahan PE, Kikinis R, Taouli B, Fennessy F, Kalpathy-Cramer J. Variations of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Evaluation of Breast Cancer Therapy Response: A Multicenter Data Analysis Challenge. Translational Oncology, 2014; 7:153-66. PMCID: PMC3998693
  27. Atuegwu NC, Li X, Arlinghaus LR, Abramson RG, Williams JM, Chakravarthy AB, Abramson V, Yankeelov TE. Longitudinal, Inter-modality Registration of Quantitative Breast PET and MRI Data Acquired Before and During Neoadjuvant Chemotherapy: Preliminary Results. Medical Physics, 2014; 41:052302. PMCID: PMC4000383
titleThese refer to the QIN-Breast Collection data, created before submission to TCIA
  1. Li X, Dawant BM, Welch EB, Chakravarthy AB, Freehardt D, Mayer I, Kelley M, Meszoely I, Gore JC, Yankeelov TE. Validation of an algorithm for the nonrigid registration of longitudinal breast MR images using realistic phantoms. Medical Physics, 2010; 37:2541-52. PMCID: PMC2881925
  2. Atuegwa NC, Gore JC, Yankeelov TE. Using Quantitative Imaging Data to Drive Mathematical Models of Tumor Growth and Treatment Response. Physics in Medicine and Biology, 2010; 55:2429-49. PMCID: PMC2897238
  3. Yankeelov TE, Arlinghaus L, Li X, Gore JC. The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer. Seminars in Oncology, 2011; 38:16-25. PMCID: PMC3073543
  4. Arlinghaus L, Li X, Levy M, Smith D, Welch WB, Gore JC, Yankeelov TE. Current and Future Trends in Magnetic Resonance Imaging Assessments of the Response of Breast Tumors to Neoadjuvant Chemotherapy. Journal of Oncology, 2010. pii: 919620. Epub 2010 Sep 29. PMCID: PMC2952974
  5. Arlinghaus LR, Welch EB, Chakravarthy AB, Farley JS, Gore JC, Yankeelov TE. Motion and distortion correction in diffusion-weighted MRI of the breast at 3T. Journal of Magnetic Resonance Imaging, 2011; 33:1063-70. PMCID: PMC3081111
  6. Gore JC, Manning HC, Quarles CC, Waddell KW, Yankeelov TE. Magnetic Resonance in the Era of Molecular Imaging of Cancer. Magnetic Resonance Imaging, 2011; 29:587-600. PMCID: PMC3285504
  7. Arlinghaus LR, Li X, Rahman AR, Welch EB, Xu L, Gore JC, Yankeelov TE. On the Relationship Between the Apparent Diffusion Coefficient and Extravascular Extracellular Volume Fraction in Human Breast Cancer. Magnetic Resonance Imaging, 2011; 29:630-8. PMCID: PMC3100356
  8. Smith DS, Welch EB, Li X, Arlinghaus LD, Loveless ME, Koyama T, Gore JC, Yankeelov TE. Quantitative effects of accelerated dynamic contrast enhanced MRI data using compressed sensing. Physics in Medicine and Biology, 2011; 56:4933-46. PMCID: PMC3192434
  9. Li, X, Welch EB, Chakravarthy B, Mayer I, Meszeoly I, Kelley M, Means-Powell J, Gore JC, Yankeelov TE. A novel AIF tracking method and comparison of DCE

  10. -MRI parameters using individual and population-based AIFs in human breast cancer. Physics in Medicine and Biology, 2011; 56:5753-69. PMCID: PMC3176673


Collection:  QIN HeadNeck


  1. Ahmadvand P, Duggan N, Bénard F, Hamarneh G. Tumor Lesion Segmentation from 3D PET Using a Machine Learning Driven Active Surface. MLMI 2016 in conjunction with the 19th Int'l Conference on MICCAI. (link)

  2. Fedorov A, Clunie D, Ulrich E, Bauer C, Wahle A, Brown B, Onken M, Riesmeier J, Pieper S, Kikinis R, Buatti J, Beichel RR. (2016DICOM for quantitative imaging biomarker development: a standards based approach to sharing clinical data and structured PET/CT analysis results in head and neck cancer researchPeerJ 4:e2057 (link)
  3. Beichel RR., Van Tol M., Ulrich EJ., Bauer C., Chang T., Plichta KA., Smith BJ., Sunderland JJ., Graham MM., Sonka M., Buatti JM. 2016. Semiautomatedsegmentation of head and neck cancers in 18F-FDG PET scans: Ajust-enough-interaction approach. Medical physics 43:2948–2964. DOI:


  1. Mazurowski MA, Zhang J, Grimm LJ, Yoon SC, Silber JI. Radiogenomic Analysis of Breast Cancer: Luminal B Molecular Subtype Is Associated with Enhancement Dynamics at MR Imaging. Radiology, 2014. doi: 10.1148/radiol.14132641 (link)
  2. Lavasani, S. N., A. F. Kazerooni, et al. (2015). Discrimination of Benign and Malignant Suspicious BreastTumors Based on Semi-Quantitative DCE-MRI ParametersEmploying Support Vector Machine. Frontiers in Biomedical Technologies 2(2): 397-403.

  3. Anand, S., V. Vinod, et al. Application of Fuzzy c-means and Neural networks to categorize tumor affected breast MR Images. International Journal of Applied Engineering Research 10(64): 2015.

  4. Guo, W., H. Li, et al. (2015). Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data. Journal of Medical Imaging 2(4): 041007-041007.

Collection: TCGA-GBM

  1. Prasanna, P., Patel, J., Partovi, S. et al. Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.  Eur Radiol (2016) pp 1–10. doi:10.1007/s00330-016-4637-3

  2. Mulvey M, Muhyadeen S,  Sinha U. Classification of Glioblastoma Multiforme Molecular Subtypes Using Three-Dimensional Multi-Modal MR Imaging Features. Med. Phys. 43, 3373 (2016); (link)

  3. Ren X, Cui Y, Gao H,  Li, R. Identifying High-Risk Tumor Volume Based On Multi-Region and Integrated Analysis of Multi-Parametric MR Images for Prognostication of Glioblastoma. Med. Phys. 43, 3751 (2016); (link)
  4. Dunn WD Jr,  Aerts HJWL, et al.  Assessing the Effects of Software Platforms on Volumetric Segmentation of Glioblastoma.   J   Neuroimaging Psychiatry Neurol 2016. 1(2): 64-72.
  5. Upadhaya T, Morvan Y, et al. Prognosis classification in glioblastoma multiforme using multimodal MRI derived heterogeneity textural features: impact of pre-processing choices. Proc. SPIE 9785, Medical Imaging 2016: Computer-Aided Diagnosis, 97850W (March 24, 2016); (link)
  6. Upadhaya T, Morvan Y, et al. Prognostic value of multimodal MRI tumor features in Glioblastoma multiforme using textural features analysis. In Biomedical Imaging (ISBI), 2015 IEEE 12th International Symposium on, pp. 50-54. IEEE, 2015.

  7. Upadhaya T, Morvan Y, et al. A framework for multimodal imaging-based prognostic model building: Preliminary study on multimodal MRI in Glioblastoma Multiforme. IRBM. 2015 Nov 30;36(6):345-50.

  8. Reza SM, Mays R, Iftekharuddin KM, editors. Multi-fractal detrended texture feature for brain tumor classification. SPIE Medical Imaging; 2015: International Society for Optics and Photonics.

  9. Nabizadeh N, Kubat M. Brain tumors detection and segmentation in MR images: Gabor wavelet vs. statistical features. Computers & Electrical Engineering. 2015.

  10. Natteshan N, Jothi JAA. Automatic Classification of Brain MRI Images Using SVM and Neural Network Classifiers.  Advances in Intelligent Informatics: Springer; 2015. p. 19-30. (link)

  11. Zhang J, Barboriak DP, Hobbs H, Mazurowski MA. A fully automatic extraction of magnetic resonance image features in Glioblastoma patients. Medical physics. 2014;41(4):042301.

  12. Wangaryattawanich P, Wang J, Thomas GA, Chaddad A, Zinn PO, Colen RR, editors. Survival analysis of pre-operative GBM patients by using quantitative image features. Control, Decision and Information Technologies (CoDIT), 2014 International Conference on; 2014: IEEE.

  13. Colen RR, Wang J, Singh SK, Gutman DA, Zinn PO. Glioblastoma: Imaging Genomic Mapping Reveals Sex-specific Oncogenic Associations of Cell Death. Radiology. 2014.

  14. Colen RR, Vangel M, Wang J, Gutman DA, Hwang SN, Wintermark M, Rajan J, Jilwan-Nicola M, Chen JY, Raghavan P, Holder CA, Rubin D, Huang E, Kirby J, Freymann J, Jaffee CC, Flanders A, Zinn PO. Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project.BMC Medical Genomics, 2014. 7(1):30. doi:10.1186/1755-8794-7-30 (link)
  15. Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, Chesier SH, Napel S, Zaharchuk G, Plevritis SK. Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features. Radiology, 2014. doi: 10.1148/radiol.14131731 (link)
  16. Mazurowski MA, Zhang J, Peters KB, and Hobbs H. Computer-extracted MR imaging features are associated with survival in glioblastoma patients. Journal of Neuro-Oncology. 2014 Aug 24 [Epub ahead of print] doi: 10.1007/s11060-014-1580-5 (link)
  17. Jain R, Poisson L, Gutman D, Scarpace L, Hwang SN, Holder C, Wintermark M, Colen RR, Kirby J, Freymann J, Jaffe C, Mikkelsen T, Flanders A. Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor. Radiology. 2014 Aug;272(2):484-93. doi: 10.1148/radiol.14131691. Epub 2014 Mar 19. 2014 (link)
  18. Nicolasjilwan M, Hu Y, Yan C, Meerzaman D, Holder CA, Gutman D, et al. Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients. Journal of Neuroradiology, July 2014. doi: 10.1016/j.neurad.2014.02.006

  21. Kwon D, Shinohara RT, Akbari H, Davatzikos C. Combining Generative Models for Multifocal Glioma Segmentation and Registration.  Medical Image Computing and Computer-Assisted Intervention–MICCAI 2014: Springer; 2014. p. 763-70.

  24. Gutman DA, Cooper LAD, Hwang SN, Holder CA, Gao J, Aurora TD, Dunn WD, Scarpace L, Mikkelsen T, Jain R, Wintermark M, Jilwan M, Raghavan P, Huang E, Clifford RJ, Monqkolwat P, Kleper V, Freymann J, Kirby J, Zinn PO, Moreno CS, Jaffe C, Colen R, Rubin DL, Saltz J, Flanders A, Brat DJ. MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set. Radiology. 2013 May:267(2):560-569,doi:10.1148/radiol.13120118 (link)
  25. Jain R, Poisson L, Narang J, Gutman D, Scarpace L, Hwang SN, Holder C, Wintermark M, Colen RR, Kirby J, Freymann J, Brat DJ, Jaffe C, Mikkelsen T. Genomic Mapping and Survival Prediction in Glioblastoma: Molecular Subclassification Strengthened by Hemodynamic Imaging Biomarkers. Radiology, 2013 Apr:267(1):212 –220, doi:10.1148/radiol.12120846 (link)
  26. Mazurowski MA, Desjardins A, Malof JM. Imaging descriptors improve the predictive power of survival models for glioblastoma patients. Neuro-oncology, 2013. 15(10):1389-1394 (link)
  27. Zinn PO, Colen RR. Imaging Genomic Mapping in Glioblastoma. Neurosurgery 60:126-130. Aug 2013 (link)
  28. Jain R, Poisson L, Narang J, Scarpace L, Rosenblum ML, Rempel S, Mikkelson T. Correlation of Perfusion Parameters with Genes Related to Angiogenesis Regulation in Glioblastoma: A Feasibility Study. American Journal of Neuroradiology, 2012. 33(7):1343-1348 [Epub ahead of print] (link)
  29. Zinn PO, Sathyan P, Mahajan B, Bruyere J, Hegi M, et al. A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature. PLoS ONE, 2012 7(8): e41522. doi:10.1371/journal.pone.0041522 (link)
  30. Zinn PO, Majadan B, Sathyan P, Singh SK, Majumder S, et al. Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme. PLoS ONE, 2011 6(10): e25451. doi:10.1371/journal.pone.0025451 (link)
  31. Wangaryattawanich, P., M. Hatami, et al.  "Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival." Neuro-oncology, (2015): nov117 .

  32. Kuo, J. S., K. B. Pointer, et al. (2015). "139 Human Ether-a-Go-Go-Related-1 Gene (hERG) K+ Channel as a Prognostic Marker and Therapeutic Target for Glioblastoma." Neurosurgery 62: 210-211.

  33. Zinn, P. O., M. Hatami, et al. (2015). "138 Diffusion MRI ADC Mapping of Glioblastoma Edema/Tumor Invasion and Associated Gene Signatures." Neurosurgery 62: 210.

  34. Steed, T., J. Treiber, et al. (2015). "Iterative Probabilistic Voxel Labeling: Automated Segmentation for Analysis of The Cancer Imaging Archive Glioblastoma Images." American Journal of Neuroradiology 36(4): 678-685.

  35. Lee, J., S. Narang, et al. (2015). "Associating spatial diversity features of radiologically defined tumor habitats with epidermal growth factor receptor driver status and 12-month survival in glioblastoma: methods and preliminary investigation." Journal of Medical Imaging 2(4): 041006-041006.

  36. Itakura, H., A. S. Achrol, et al. (2015). "Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities." Science Translational Medicine 7(303): 303ra138-303ra138.

  37. Cui, Y., K. K. Tha, et al. (2015). "Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images." Radiology: 150358.

  38. Lee, J., S. Narang, et al. (2015). "Spatial Habitat Features Derived from Multiparametric Magnetic Resonance Imaging Data Are Associated with Molecular Subtype and 12-Month Survival Status in Glioblastoma Multiforme." PloS one 10(9): e0136557.

  39. Rios Velazquez E, Meier R, Dunn WD Jr, Alexander B, Wiest R, Bauer S, Gutman DA, Reyes M, Aerts HJ. "Fully automatic GBM segmentation in the TCGA-GBM dataset: Prognosis and correlation with VASARI features." Sci Rep. 2015 Nov 18;5:16822. doi: 10.1038/srep16822.